Skip to main content
Clinical Trials/ITMCTR2100005210
ITMCTR2100005210
Recruiting
未知

Randomized controlled trial of acupuncture improving quality of life in patients with chronic prostatitis / chronic pelvic floor pain syndrome in acupuncture group

Beijing Fengtai Hospital of Integrated Traditional Chinese and Western Medicine0 sitesTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Beijing Fengtai Hospital of Integrated Traditional Chinese and Western Medicine
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
Male

Investigators

Sponsor
Beijing Fengtai Hospital of Integrated Traditional Chinese and Western Medicine

Eligibility Criteria

Inclusion Criteria

  • (1\) The clinical manifestations were recurrent and persistent prostate pain in the last six months, accompanied by abnormal urination and psychoneurological symptoms. At the same time, infection or other obvious pathological conditions were not confirmed, and the symptoms lasted for more than 3 months. The main clinical manifestations are pain radiated from the surrounding tissues with the prostate as the center, and pain, swelling or discomfort in the scrotum, testis, lower abdomen, perineum, lumbosacral and medial thigh; Abnormal micturition showed frequent micturition, urgent micturition, urinary pain, urethral burning, residual urine or white secretion overflowing from the urethra in the morning, at the end of urine or defecation; Mental and neurological symptoms include dizziness, tinnitus, insomnia, dreaminess, anxiety and depression, or even sexual dysfunction such as impotence and premature ejaculation;
  • (2\) Age 18\-50 years old;
  • (3\) NIH\-CPSI score \>\= 15;
  • (4\) Voluntarily participate in the trial and sign the informed consent form.

Exclusion Criteria

  • (1\) Bladder outlet obstruction, overactive bladder, neurogenic bladder, interstitial cystitis, glandular cystitis, sexually transmitted diseases, carcinoma in situ and other bladder tumors, prostate cancer, urinary tract infection, other types of prostatitis, etc;
  • (2\) Transabdominal B\-ultrasound residual urine \>\= 100ml; Maximum urinary flow rate \< 15ml /S;
  • (3\) Taking drugs to alleviate CP / CPPS symptoms or receiving non drug therapy for CP / CPPS (acupuncture, biofeedback, etc.) in recent 1 month; Taking drugs that affect lower urinary tract function;
  • (4\) Symptomatic urinary tract infection and organic diseases of urinary system;
  • (5\) Diseases affecting lower urethral function, such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, spinal cord injury, cauda equina nerve injury, stroke and multisystem atrophy;
  • (6\) Patients with severe heart, lung, brain, liver, kidney and hematopoietic system diseases, mental diseases and obvious cognitive impairment.

Outcomes

Primary Outcomes

Not specified

Similar Trials